Hematology/Oncology

Top Story

CHARM: Ethanol-free EUS-guided chemoablation safe, effective

CHARM: Ethanol-free EUS-guided chemoablation safe, effective
October 18, 2017

ORLANDO — An ethanol-free protocol for pancreatic cyst ablation followed by a combined paclitaxel and gemcitabine regimen for pancreatic neoplasia was effective and led to significant reductions in adverse events, according to research presented at the World Congress of Gastroenterology at ACG 2017.

“This is important because significantly improving the risk profile of this procedure, while preserving its efficacy, increases the attractiveness of this therapeutic option for patients with precancerous-type pancreatic cysts,” Matthew T. Moyer, MD, MS, of Penn State University Milton S. Hershey Medical Center, said during his presentation.

Meeting News

Smoking cessation appears cost-effective for lung cancer screening program

October 18, 2017
The addition of a smoking cessation intervention to a low-dose CT lung cancer screening program appeared cost-effective, according to data presented at International…
FDA News

FDA grants priority review to Lynparza for metastatic BRCA-related breast cancer

October 18, 2017
The FDA granted priority review to olaparib for the treatment of patients with germline BRCA-mutated, HER-2-negative metastatic breast cancer who have been previously…
Meeting News

‘Diffusion of responsibility’ leads to missed testing in colon cancer

October 18, 2017
ORLANDO — Though up to 17% of early-onset colon cancers carry genetic markers for Lynch syndrome, only 30% of patients diagnosed with colon cancer younger than age…
In the Journals Plus

Malignant thyroid nodules grow faster than benign nodules

October 18, 2017
Malignant thyroid nodules are more likely to grow at least 2 mm per year and increase in volume compared with benign thyroid nodules, according to findings published in…
More Headlines »
CME

Combination Strategies in Melanoma Management: What’s New and What’s Next

This activity is supported by an educational grant from Genentech, Inc.

Melanoma is the sixth most common cancer in the United States and the deadliest form of skin cancer. Although it is…
More »
Video
Meeting News

VIDEO: Letermovir CMV prophylaxis offers survival benefit in hematopoietic cell transplant patients

October 14, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME

Diagnostic and Therapeutic Challenges in Von Willebrand Disease

This activity is supported by an educational grant from Shire.

With the significant variability in the subtypes and clinical manifestations of von Willebrand disease (VWD), diagnosis…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement